Biopharm

MJ Biopharm officials couldn't be reached to comment.

U.K. Issues Recall Of Various Generics 2009

GSK Biopharm R&D is employing novel approaches to harness the therapeutic potential of biopharmaceuticals for the benefit of patients with serious autoimmune disease.

unknown title 2011

The commercial rights are licensed to Meda for all territories worldwide except for Taiwan (licensed to TTY Biopharm) and South Korea (licensed to Kunwha Pharmaceutical Co.)

unknown title 2011

Revenue for the second quarter of 2010 consisted of net sales of FARESTON ® of $599,000 and collaboration revenue of $336,000 from our former collaboration with Ipsen Biopharm Limited.

unknown title 2011

Biopharm VaxGen (OTCBB: VXGN) and diaDexus, a diagnostics company focused on cardiovascular disease, are both located in South San Francisco.

Boston Business News - Local Boston News | Boston Business Journal 2010

Biopharm VaxGen (OTCBB: VXGN) and diaDexus, a diagnostics company focused on cardiovascular disease, are both located in South San Francisco.

San Antonio Business News - Local San Antonio News | The San Antonio Business Journal 2010

Watson Pharmaceuticals, Inc. today announced that it has completed the acquisition of Eden Biopharm ...

THE MEDICAL NEWS Editors 2010

Biopharm VaxGen (OTCBB: VXGN) and diaDexus, a diagnostics company focused on cardiovascular disease, are both located in South San Francisco.

Boston Business News - Local Boston News | Boston Business Journal 2010

Biopharm Reportsreveals rapidly expanding developments in this field, with 35 candidate drugs in the pipeline (17 vaccines and 18 antibodies).

PRWeb - Daily News Feed 2010

Biopharm VaxGen (OTCBB: VXGN) and diaDexus, a diagnostics company focused on cardiovascular disease, are both located in South San Francisco.

Philadelphia Business News - Local Philadelphia News | The Philadelphia Business Journal 2010